Cargando…

Genetic Variation on Chromosome 6 Influences F Cell Levels in Healthy Individuals of African Descent and HbF Levels in Sickle Cell Patients

Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a quantitative trait locus on chromosome 6q23 was significantly associated with HbF and F cell levels in individuals of African descent. Single nucleotide polymorphisms (SNPs) in a 24-kb intergenic regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Creary, Lisa E., Ulug, Pinar, Menzel, Stephan, McKenzie, Colin A., Hanchard, Neil A., Taylor, Veronica, Farrall, Martin, Forrester, Terrence E., Thein, Swee Lay
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621086/ https://www.ncbi.nlm.nih.gov/pubmed/19148297 http://dx.doi.org/10.1371/journal.pone.0004218

Ejemplares similares

Genetic variants at HbF‐modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
por: Steinberg, Martin H.
Publicado: (2020)

miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia
por: Cyrus, Cyril, et al.
Publicado: (2022)

Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh
por: Bhagat, Sanjana, et al.
Publicado: (2012)

Association of polymorphisms in the HBG1‐HBD intergenic region with HbF levels
por: Hu, Li, et al.
Publicado: (2020)

HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines
por: Minniti, Caterina P., et al.
Publicado: (2020)

FOETAL HAEMOGLOBIN (HbF) STATUS IN ADULT SICKLE CELL ANAEMIA PATIENTS IN IBADAN, NIGERIA
por: Olaniyi, J.A., et al.
Publicado: (2010)

Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients
por: Kargutkar, Neha, et al.
Publicado: (2023)

CNTO 530 Increases Expression of HbA and HbF in Murine Models of β-Thalassemia and Sickle Cell Anemia
por: Makropoulos, Dorie A, et al.
Publicado: (2013)

The Effect of Alpha Thalassemia, HbF and HbC on Haematological Parameters of Sickle Cell Disease Patients in Ibadan, Nigeria
por: Fasola, Foluke Atinuke, et al.
Publicado: (2022)

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis
por: Sales, Rahyssa Rodrigues, et al.
Publicado: (2022)

Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
por: Finotti, Alessia, et al.
Publicado: (2023)

The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers
por: Zuccato, Cristina, et al.
Publicado: (2023)

Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF
por: Ibanez, Vinzon, et al.
Publicado: (2023)

P1473: CREATING A RANDOM FOREST CLASSIFIER TO PREDICT HBF LEVELS IN SICKLE CELL DISEASE PATIENTS
por: Rakhit, C., et al.
Publicado: (2022)

Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)
por: Brewin, John N., et al.
Publicado: (2020)

Unique Polymorphisms at BCL11A, HBS1L-MYB and HBB Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease
por: Akbulut-Jeradi, Nagihan, et al.
Publicado: (2021)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34(+) Cells from Sickle Cell Disease Patients
por: Drakopoulou, Ekati, et al.
Publicado: (2022)

Effect of Cis Acting Potential Regulators in the β Globin Gene Cluster on the Production of HbF in Thalassemia Patients
por: Dabke, Pooja, et al.
Publicado: (2013)

Chen J-J. HRI stress signaling and HbF production. Blood. 2020;135(24):2113-2114.
Publicado: (2020)

Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells
por: Yu, Xiaofei, et al.
Publicado: (2019)

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
por: Zuccato, Cristina, et al.
Publicado: (2012)

Evaluation of the Effect of miR-26b Up-Regulation on HbF Expression in Erythroleukemic K-562 Cell Line
por: Alijani, Sadegh, et al.
Publicado: (2014)

Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients
por: Cyrus, Cyril, et al.
Publicado: (2017)

Experimental Generation of SNP Haplotype Signatures in Patients with Sickle Cell Anaemia
por: Menzel, Stephan, et al.
Publicado: (2010)

COVID-19 and sickle cell disease
por: Menapace, Laurel A., et al.
Publicado: (2020)

Therapeutic advances in sickle cell disease in the last decade
por: Shet, Arun S., et al.
Publicado: (2017)

In Vitro and In Vivo Studies for the Investigation of γ-Globin Gene Induction by Adhatoda vasica: A Pre-Clinical Study of HbF Inducers for β-Thalassemia
por: Iftikhar, Fizza, et al.
Publicado: (2022)

The carrier state for sickle cell disease is not completely harmless
por: Xu, Julia Zhe, et al.
Publicado: (2019)

MBD2a–NuRD binds to the methylated γ-globin gene promoter and uniquely forms a complex required for silencing of HbF expression
por: Shang, Shengzhe, et al.
Publicado: (2023)

miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation
por: Simbula, Michela, et al.
Publicado: (2023)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer
por: Mtatiro, Siana N, et al.
Publicado: (2015)

P-028: CIRCULATING CD34+CD235A+ CELL COUNT CORRELATES WITH LEVELS OF HBF IN SICKLE CELL ANEMIA PATIENTS UNDER HYDROXYUREA TREATMENT
por: J., MILHOMENS, et al.
Publicado: (2022)

Fetal‐haemoglobin enhancing genotype at BCL11A reduces HbA(2) levels in patients with sickle cell anaemia
por: Adeyemo, Titilope A., et al.
Publicado: (2021)

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease
por: Barbu, Emilia Alina, et al.
Publicado: (2019)

PB2221: A SYSTEMATIC LITERATURE REVIEW DESCRIBING PROTECTIVE EFFECTS OF HBF IN SICKLE CELL DISEASE OUTCOMES
por: Mitelman, O., et al.
Publicado: (2022)

World Sickle Cell Day 2016 : A time for appraisal
por: Thein, Mya S., et al.
Publicado: (2016)

A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia
por: Adeyemo, Titilope A., et al.
Publicado: (2018)

Genetic variants of PKLR are associated with acute pain in sickle cell disease
por: Wang, Xunde, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8pfm52oe7hmf74ir66v2sio0i